Shionogi (Germany) Today
| SH0 Stock | EUR 12.70 0.10 0.78% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Shionogi is trading at 12.70 as of the 30th of November 2024. This is a 0.78 percent decrease since the beginning of the trading day. The stock's lowest day price was 12.7. Shionogi has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days.Shionogi has reported 1 for 3 split on 27th of September 2024. Equity ratings for Shionogi Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
Shionogi Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. Shionogi Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan. The company has 298.16 M outstanding shares. More on Shionogi Co
Moving together with Shionogi Stock
Moving against Shionogi Stock
Shionogi Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shionogi's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shionogi or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
Shionogi Co (SH0) is traded on Frankfurt Exchange in Germany and employs 5,693 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.19 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shionogi's market, we take the total number of its shares issued and multiply it by Shionogi's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shionogi classifies itself under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 298.16 M outstanding shares.
Shionogi Co has accumulated about 2.4 B in cash with 102.07 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.64.
Check Shionogi Probability Of Bankruptcy
Ownership AllocationShionogi shows a total of 298.16 Million outstanding shares. Over half of Shionogi's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Shionogi. Please watch out for any change in the institutional holdings of Shionogi as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shionogi Ownership Details
Shionogi Risk Profiles
Although Shionogi's alpha and beta are two of the key measurements used to evaluate Shionogi's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.75 | |||
| Standard Deviation | 3.03 | |||
| Variance | 9.17 | |||
| Risk Adjusted Performance | (0.01) |
Shionogi Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shionogi without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Shionogi Corporate Management
Elected by the shareholders, the Shionogi's board of directors comprises two types of representatives: Shionogi inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shionogi. The board's role is to monitor Shionogi's management team and ensure that shareholders' interests are well served. Shionogi's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shionogi's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kohji Hanasaki | Sr Division | Profile | |
| Isao Teshirogi | CEO Chairman | Profile | |
| Kazuhiro Hatanaka | Sr Division | Profile | |
| Yoshihiro Furuya | VP Office | Profile | |
| Ryuichi Kiyama | Sr Division | Profile | |
| Takeshi Shiota | Ethics Assurance | Profile | |
| John Keller | Sr Unit | Profile |
Other Information on Investing in Shionogi Stock
Shionogi financial ratios help investors to determine whether Shionogi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shionogi with respect to the benefits of owning Shionogi security.